Hewlett Packard (HP) has surely been doing very well in its field of computing, printing, and digital imaging. But now it forays into science too. Well, I’m sure you all are as shocked as what I was when I first came across this news. Read on to know more.
HP has announced that it has developed a product that can not only perform its primary function but can simultaneously also release several types of medicines into an individual’s bloodstream through a skin patch that contains 1,000 “microneedles” per square inch, according to TheStreet.
Based on HP’s printer technology, the microneedles just about penetrate the surface of the skin, therefore not being a highly painful affair which is generally the case when conventional hyperemic needles are pierced into the body. The microneedles in the skin patch are made utilizing the same technology that HP employs to develop the tiny printer nozzles that spray ink on paper. And the heating element used on an inkjet’s printhead is also included into the patch.
Further more, the substantial amount of microneedles, combined with a microprocessor, mean the patch can be used to electronically deliver multiple drugs, with different dosage and timing settings.
“We really think it will open up a wide range of new applications in the drug delivery arena,” maintained Joe Beyers, Vice President of HP’s intellectual property licensing division.
HP plans to license the technology to a newly-formed Irish company called Crispon. The company essentially is in the area of monitoring and treatment of diabetes and gastroesophageal reflux disorder and some time back announced 2.3 million euros ($3.1 million) in seed financing.
According to Beyers, Crospon still needs to put the patch through additional testing and go through the approval process. Now through this bit, one can conclude that the product’s commercial availability is still perhaps a few years away.